NCT01919008View on ClinicalTrials.gov

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 26, 2012

Primary Completion Date

June 22, 2012

Study Completion Date

June 22, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

FK949E

Oral

Trial Locations (1)

Unknown

Kanto

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01919008 - Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter